Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chaya Kapugama
Corrigendum to “Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia”
Case Reports in Psychiatry
Psychiatry
Mental Health
Related publications
The Influence of Switching From Oral Risperidone to Risperidone Long-Acting Injection on the Clinical Symptoms and Cognitive Function in Schizophrenia
Therapeutic Advances in Psychopharmacology
Pmh25 - Early Administration of Aripiprazole Long-Acting Injectable in Acute Inpatients With Schizophrenia Reduces the Cost of Hospitalization
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Long-Acting Phenothiazines in Schizophrenia
BMJ
Long-Acting Phenothiazines in Schizophrenia.
BMJ
Treatment-Completion Rates With Olanzapine Long-Acting Injection Versus Risperidone Long-Acting Injection in a 12-Month, Open-Label Treatment of Schizophrenia: Indirect, Exploratory Comparisons
International Journal of General Medicine
Medicine
Long-Term Safety and Efficacy of Olanzapine Long-Acting Injection in Patients With Schizophrenia or Schizoaffective Disorder
International Clinical Psychopharmacology
Psychiatry
Mental Health
Pharmacology
Stability of Negative Symptoms of Schizophrenia
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
Post-Injection Delirium/Sedation Syndrome in Patients With Schizophrenia Treated With Olanzapine Long-Acting Injection, I: Analysis of Cases
BMC Psychiatry
Psychiatry
Mental Health
Pmh40 - Cost-Minimisation Analysis of Second Generation Long Acting Injectables (Risperidone , Paliperidone, and Aripiprazole) for Schizophrenia in Spanish Medium-Long Term Care Psychiatric Units
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
